Shares of CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $36.24, but opened at $33.91. CochLear shares last traded at $33.94, with a volume of 1,330 shares traded.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the stock. UBS Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Thursday, April 23rd. Zacks Research upgraded CochLear to a “hold” rating in a research report on Friday, April 17th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.
View Our Latest Report on CHEOY
CochLear Trading Down 3.0%
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
See Also
- Five stocks we like better than CochLear
- Microsoft Build 2026 Is Really Just One Big AI Stress Test
- Slice of the Pie: Why Yum’s Deal Lifts QSR
- 3 Most Upgraded Stocks Last Month According to MarketBeat
- MongoDB Is the Latest SaaS Apocalypse Victim to Say “Not Today”
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
